A new mouse model demonstrates that a genetic mutation in the FOXP1 gene leads to brain degeneration, causing perception and behavior problems. The study provides valuable insights into the molecular mechanisms underlying autism.
A clinical study led by Heidelberg University Hospital's Neurology and Neurosurgery found that hemicraniectomy significantly improves survival rates in elderly patients after a major stroke. The procedure reduces mortality from 70% to 33% but also results in nearly 30% of patients being very severely disabled.
Professor Thomas Korff's work reduces experimental animals and promotes human umbilical cord cells to mimic vessel walls. His methods decrease animal distress and costs, while improving research results.
A large-scale study found that two new psychotherapeutic methods and a specialized form of standard psychotherapy can effectively treat anorexia nervosa in adults. Patients continued to show significant weight gains even after therapy concluded, with improved BMI and mental health outcomes.
A study published in Annals of Surgery found that immediate surgery reduces complications and shortens hospital stays by up to 50% compared to delaying surgery. Patients who underwent early surgery had fewer complaints and were discharged earlier, resulting in lower hospitalization costs.
Researchers at Heidelberg University Hospital have developed a new method to detect drug interactions at very low doses, which can be used to study interactions between drugs without posing risks to patients. This breakthrough improves the reliability of pharmacological studies and has the potential to reduce medication errors.
A study found that kidney transplants performed in Europe have higher survival rates after 5 and 10 years compared to those in the United States. The disparity may be attributed to the lack of cost reimbursement for anti-rejection drugs in the US, leading to poorer outcomes among certain demographics.
Researchers discovered that a protein called SAMHD1 protects resting T helper cells from HIV replication by degrading genetic information. The study provides new insights into the immunodeficiency syndrome AIDS and could lead to new treatments for HIV.
Heidelberg University Hospital's Breast Center reports excellent treatment results for breast cancer patients in Germany. Eighty-six percent of patients survived the first five years after onset of treatment and 80% remained disease-free during this period.
Researchers have developed a mouse model that can treat a severe congenital disorder by supplementing pregnant mice with mannose, increasing the production of essential sugar chains. This breakthrough may offer a new therapeutic approach for children with CDG-Ia, who currently have no treatment options.
Researchers discovered that a degradation product of defective hemoglobin blocks the establishment of a trafficking system used by the malaria parasite, preventing circulatory disorders and neurological complications. The study provides new insights into the molecular mechanism behind the protective effect of sickle-cell anemia against...
A Heidelberg University Hospital study found that a single protein mediates pathological remodeling processes causing varicose veins. The protein triggers changes in wall architecture, leading to increased cell proliferation and enzyme production.
A newly discovered metabolic pathway involving the dioxin receptor has been found to promote tumor growth and weaken the immune system in glioma patients. The research, published in Nature, suggests that inhibiting this pathway could be a potential target for cancer treatment.
In a breakthrough study, three young children with severe hemolytic-uremic syndrome (HUS) after an EHEC infection have been successfully treated with eculizumab. The treatment, which targets the immune system's destructive reactions, led to dramatic improvements in kidney function and neurological disorders.
Researchers at Heidelberg University Hospital developed a therapy concept to treat high-risk patients with sensitized kidneys, achieving comparable transplant survival rates as non-immunized patients. After one year, 95% of transplanted kidneys were still functioning.
Researchers found that angiotensin II promotes brain inflammation in multiple sclerosis, but blocking its receptors with Candesartan decreases inflammation and resolves paralysis. The protective mechanism works only in the central nervous system, and the study suggests a new potential treatment for MS.
Researchers found that administering antibiotics during the liver stage of malaria infection generates strong protective immunity in mice. The treatment prevents malaria parasites from infecting red blood cells and builds long-term immunity against subsequent infections.
A multicentric clinical phase II study led by Professor Dr. Peter Dreger found that allogeneic stem cell transplantation significantly improved tolerance and cured nearly half of patients with therapy-resistant chronic leukemia, regardless of genetic risk profile or prior treatment outcomes.
A clinical study by Heidelberg cardiologists found that acupuncture increases skeletal muscle strength, allowing heart patients to cover greater distances during exercise. The treatment also reduced inflammation messengers in the blood, which contribute to muscle fatigue.
Researchers at Heidelberg University Hospital found a promising new treatment for pancreatic cancer combining sorafenib with sulforaphane, an anti-cancer compound in broccoli. The combination treatment inhibits resistant tumor stem cells and blocks metastasis without causing additional side effects.
Researchers at Heidelberg University Hospital have identified new mutations in the SHANK2 gene that contribute to autism and mental retardation. The study found that a correct inner structure of nerve cell synapses is necessary for normal language, social competence, and cognitive development.
Researchers at Heidelberg University Hospital discovered that inhibiting communication between nerve cells accelerates odor discrimination in mice. The study confirmed the function of lateral inhibition, which enables quick and reliable recognition of similar smells, using genetic manipulation and electrophysiological measurements.
A study published in Intensive Care Medicine found that the AiDKlinik drug information system significantly reduces serious events resulting from drug interactions in ICU patients. The system, which includes over 64,000 drugs, helps physicians minimize adverse reactions by 43% and critical events like arrhythmia by up to 80%.
A study published in PNAS found that a synaptic maturation disorder, particularly with the neuroligin-1 protein, may trigger autism. The research suggests that an insufficient amount of this protein can impair the maturation process at nerve terminals, leading to communication problems and weaknesses in social contacts.
A 64-year-old woman with severe depression was treated with deep brain stimulation of the habenula, showing significant improvement and long-term remission. The procedure is a new treatment option for therapy-resistant depression, building on existing knowledge of the habenula's role in the condition.
Researchers at Heidelberg University Hospital discovered that malaria parasites alternate between phases of rapid gliding and firm adhesion to surface. This 'stick-slip' mechanism enables the parasite to move rapidly over a long time, necessary for successful transmission of the disease.
Researchers have identified a new genetic cause of cardiac failure, specifically mutations in the nexilin protein that destabilize the Z-disk. This discovery has significant implications for clinical therapy, suggesting that early treatment with stress-reducing medications may prevent progressive damage to the heart.
The world's largest congress on ion therapy brought together leading experts to discuss the latest scientific and clinical developments in radiation therapy. The meeting marked a significant milestone in the technology and clinical application of ion radiation, with over 70,000 patients worldwide treated so far.
A new approach to treating malignant brain tumors has been discovered, with chemotherapy alone proven to be just as effective as traditional radiation therapy. The study identified a key gene mutation called IDH1 that predicts a better prognosis for patients, regardless of treatment.
The HIV Nef protein inhibits cell mobility in immune cells, disrupting their ability to establish contact and combat the virus. This mechanism may lead to the malfunction of B-lymphocytes in AIDS patients.
A new tumor marker has been identified for brain tumor resistance, allowing for targeted therapy approaches. The discovery of a
Researchers discovered that genetic material regulators beyond the SHOX gene itself play a crucial role in developing growth disorders. A study of 893 patients with short stature found that enhancer mutations, far from the affected gene, can cause the same clinical symptoms as direct gene mutations.
Researchers at Heidelberg University Hospital discovered that mice with thick blood formed larger but more stable plaques, reducing the risk of vascular obstruction. However, long-term use of anticoagulants reversed these advantages, highlighting the need for caution when prescribing these medications.
Researchers found that ACE inhibitors and AT1R blockers suppressed immune cells promoting inflammation, while increasing anti-inflammatory immune cells, reversing neuroinflammation and paralysis in mice. Clinical trials are planned to investigate the efficacy of these medications in humans with multiple sclerosis.
Researchers from Heidelberg University Hospital have identified a new target for treating chronic hepatitis C: the protein cyclophilin A. Inhibiting this protein blocks virus replication and has two complementary effects, making it a promising approach to therapy.
A new computer system has been successfully tested at Heidelberg University Hospital to improve pain therapy for cancer patients. The system, AiDPainCare, was found to have little variance from international guidelines and reduced patient pain.
Heidelberg researchers discovered processes in brain metabolism that explain anorexic patients' rigid behavior, suggesting new therapy approaches. The study's results contribute to a better understanding of anorexia and its neurobiological factors.
Researchers at Heidelberg University Hospital have discovered that the metabolic disease glutaric aciduria type I causes not only acute but also chronic toxic damage to the developing brain. Therapy should be extended to prevent long-term brain damage and should be started early, even before birth.
A randomized trial of 200 patients found that midline and transverse incisions had the same healing process and post-surgical pain perception. However, wound infections were more frequent for transverse incisions, possibly due to circulatory problems.
Cancer patients often suffer from severe pain due to tumors releasing signal substances that make nerve cells sensitive; a new approach involves injecting proteins that block these effects. This discovery opens up new prospects in the fight against cancer pain and potentially reduces side effects for patients.
Researchers from Heidelberg University Hospital have discovered that combining methylene blue with newer malaria medications is twice as effective in curbing the spread of malaria parasites than standard therapy. This new approach has significant implications for eradicating the disease, particularly among children under five who are m...
Researchers create first 3D model of dengue virus replication, providing insight into the process and offering new approaches for developing measures to prevent or treat dengue fever. The study provides crucial information for developing therapy against this infectious disease.
Researchers at Heidelberg University Hospital have shown that certain immune cells in the blood inhibit inflammation after a stroke. Regulatory T lymphocytes (Treg) play a key role in this protection and may offer a new approach to stroke therapy.
Researchers discover HIV counteracts human cell protection by marking proteins for rapid destruction, but not in rats. Disrupting this interaction could be a promising strategy for therapy to increase cells' protective mechanisms.
Scientists at Heidelberg University Hospital have identified a previously unknown protein called SCAI that inhibits the movement and spread of tumor cells. The study suggests that SCAI could be an interesting starting point for research into new mechanisms for fighting cancer.
Researchers have discovered new tumor markers that can accurately predict the course of disease and treatment response in childhood brain tumors. These markers, found in medulloblastoma DNA, can help adjust therapy intensity to reduce damage and secondary malignancies.
Heidelberg cardiologists have discovered a single amino acid mutation that can severely limit heart function in zebrafish, a model similar to the human genome. The researchers hope to develop new therapies for patients with cardiac insufficiency by targeting this mutation.
Researchers from Heidelberg University Hospital found that CaMKII delta enzyme activates stress response and hypertrophy of the heart. Genetic suppression of this enzyme protects mice from chronic cardiac insufficiency, offering a promising approach for systematic prevention.
Heidelberg researchers use cryo-electron tomography to visualize the structure of Lyme disease bacteria, revealing differences in motility systems that may explain varying symptoms between European and North American patients. The study provides new insights into the complex biology of borreliosis and potential therapeutic targets.
Researchers have successfully prevented cystic fibrosis lung disease in a mouse model by administering amiloride, a drug that inhibits hyperactive sodium channels. Early inhalation treatment prevents chronic lung damage and airway inflammation, providing a new therapeutic approach for the widespread genetic disease.